ABOUT PWR          EVENTS        OUR RESEARCH        SPONSORSHIP          FR

Presented by

11 | 19 | 2024

Women
Chefs Rise

for a good cause

We’re back. Aiming higher.

Join us and help increase survival rates in women’s cancer

An incredible evening you’ll never forget.

A unique culinary experience at Portus 360. For only one night, you can experience some of the best female chef creations from Montreal renowned restaurants rising together for a good cause.

Women chefs unite.

This year’s event will rise above expectations, hosted by Montreal Chef Helena Loureiro's Portus 360 with a 6-course meal from a collaboration of chefs, all working together to create a unique menu from different tastes and palettes, it is sure to delight and surpass expectations.

Cocktails & greetings.

Guests can expect a chic welcome cocktail & appetizers with an opportunity to meet the many female chefs who are contributing to the first ever recipe magazine. Funds from purchases go directly to PWR. Here’s who’s coming:


  • Josée di Stasio (host and cookbook author)
  • Dyan Solomon (Olive et Gourmando)
  • Geneviève Everell (Miss Sushi à la maison)
  • Maria-José de Frias (Le Virunga)
  • Émilie Bégin (Le Butterfly)
  • Chloé Ouellet (Au Pâturage)
  • Mia Roberts (Iconoglace)
  • Charlotte Maurin (Butter Blume)

Limited tickets available.

Tickets on sale now. Seating limited. Donation receipts for tax purposes will be provided after the event for a portion of the cost of the ticket.

A good cause and great eats

Featuring an all-star team of local female chefs

Chef Helena Loureiro

Chef and Restaurateur Portus 360 & Helena

Chef Helena Loureiro, renowned for her upscale Portuguese cuisine, began her culinary journey in Serra de Santo Antonio and honed her skills in Lisbon and Montreal. In 2003, she opened Portus Calle, an acclaimed Portuguese restaurant in Montreal. Her dedication to culinary excellence and her ability to create memorable dining experiences have made her restaurants a cherished destination for those seeking authentic Portuguese flavors in a sophisticated setting.

Stay tuned for the unveiling of the all-female chef team

A first-of-its-kind recipe magazine launch

A first-of-its-kind book-style magazine launch. We like to call it a “bookazine”. A magazine featuring inspiring stories & the latest from PWR’s  researchers paired with a collection of recipes from 15 chefs, a mix of renowned Montreal chefs and even including some homemade cooking from our researchers’ mothers. This cookbook is a symphony of complimentary flavours that is sure to turn just about anyone into the master of their kitchen.

Recipes curated and collected from:

Stories featuring:

  • Daiva Jaugelis, cervical cancer survivor
  • Gaëlle Cerf, chef and breast cancer survivor
  • Dr. Alfieri, radiation oncologist
  • Dr. Hijal, radiation oncologist
  • La Roche-Posay, Beauty in science
  • Assunta Alfieri - Dr. Joanne Alfieri's mother
  • Charlotte Maurin - Le Butterblume
  • Chloé Ouellet - Au Pâturage
  • Dyan Solomon - Olive & Gourmando
  • Emilie Bégin - Le Butterfly
  • Fisun Ercan - Bika Farm and Cuisine
  • Geneviève Everell - Miss Sushi à la maison
  • Geneviève O’Gleman - nutritionist and cookbook author
  • Helena Loureiro - Portus 360 & Helena
  • Isabelle Deschamps Plante – Ricardo
  • Josée di Stasio - host and cookbook author
  • Lesley Chesterman - food columnist and cookbook author
  • Malak Hijal - Dr. Tarek Hijal's mother
  • Maria-José de Frias - Le Virunga
  • Mia Robert – Iconoglace


Available for pre-order

Order now for delivery after November 20th, 2024. All proceeds go directly to PWR in support of better outcomes for women with cancer.

Title Sponsor

La Roche-Posay’s mission is to improve the quality of life of people living with sensitive or weakened skin due to cancer. Through their ongoing commitment to research in oncology, they support future innovations in cancer. As our title sponsor, they are helping us get one step closer to increasing survival rates in women’s cancers. We are incredibly grateful to them for their efforts in ensuring women remain confident and true to themselves, even when confronting these illnesses.


Thank you to our sponsors and partners

Silver

Bronze

Media Sponsor

Partners

PWR

The cause

The Division of Radiation Oncology at McGill University Health Centre treats over 750 new patients per year diagnosed with either breast or gynecological cancer. With over 9000 Canadian women dying from one of these cancers every year, the Program for Women’s cancer Research (PWR) will improve outcomes for women with cancer.

Our aim

We are striving to push further and think bigger. The expansion of our research program depends on the generous donations of sponsors and donors. Our fundraising event is an opportunity for Montrealers to celebrate our city’s culinary talent, connect with family and friends and experience an unforgettable evening with breathtaking views. Because at the heart of everything we do, we look to increase hope, connections and time with loved ones.


We will continue to reach for the stars.


Thank you for supporting PWR.

Team leads

Our Reseachers

Joanne Alfieri MMEd, MDCM, FRCPC

Tarek Hijal MDCM, FRCPC

Co-Director, Program for Women’s Cancer Research Radiation Oncologist and Director, Division of Radiation Oncology at the MUHC Associate Investigator, Research Institute of the MUHC Associate Professor, Gerald Bronfman Department of Oncology, McGill University

Co-Director, Program for Women’s Cancer Research Radiation Oncologist, MUHC Associate Investigator, Research Institute of the MUHC Associate Professor & Associate Chair (Education), Gerald Bronfman Department of Oncology, McGill UniversityAssistant Dean, PGME Curricula, Faculty of Medicine and Health Sciences, McGill University

Clinical interests: 

Clinical interests:

Dr. Hijal’s work on breast cancer includes the introduction of intraoperative radiotherapy in Quebec, through the use of the Intrabeam system that allows patients to be treated with radiation therapy during the surgery, saving them several weeks of post-operative treatment.

Dr. Alfieri’s work in gynecological malignancies (endometrial, cervical, vaginal, vulvar, and ovarian cancers) includes the creation of an MRI-guided brachytherapy program at the MUHC, allowing high doses of radiation to be delivered with utmost precision from inside the diseased organ, sparing precious surrounding healthy tissues and minimizing side effects.

Current research:

Current research:

Dr. Hijal’s research focuses on assessing new radiation treatments for breast and rectal cancers, including one-day radiation treatments for breast cancer. He is also involved in improving radiotherapy care through the use of technology and machine learning.

Her current research interests lie in the evaluation of the MRI-guided brachytherapy program with the aim of decreasing recurrences and minimizing long-term side effects in gynecological cancer patients. She is also investigating innovative treatments for gynecological malignancies, such as the combination of radiation with immunotherapy and using advanced technologies to reduce overall treatment time for these patients.

Recent Publications:

Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: Early results of a phase 2 study. Mahmoud D, Yassa M, Alvarado L, Lambert C, Meterissian S, Anderson D, Tremblay F, Otaky N, Keyserlingk J, Panet-Raymond V, Kopek N, David M, Duclos M, Pembroke C, Fleiszer D, Meguerditchian AN, Loutfi A, Lavigne D, Hijal T. Radiother Oncol 2024 Aug 30:200:110510. DOI:10.1016/j.radonc.2024.110510


Single preoperative radiation therapy with delayed surgery for low-risk breast cancer: Oncologic outcome, toxicity and cosmesis of the SPORT-DS phase I trial. Lavigne D, Hijal T, Vavassis P, Guilbert MC, Sideris L, Dubé P, Gervais MK, Leblanc G, Dufresne MP, Nguyen D, Tiberi D, Mahmoud D, Yassa M. Radiother Oncol. 2024 Aug 30:200:110515. DOI: 10.1016/j.radonc.2024.110515


Barrier films or dressings for the prevention of acute radiation dermatitis in breast cancer: a systematic review and network meta-analysis. Wong HCY, Lee SF, Caini S, Wai Chan A, Kwan JYY, Waddle M, Sonis S, Herst P, Alcorn S, Bonomo P, Wong C, Corbin K, Choi JI, Rembielak A, AlKhaifi M, Nader Marta G, Rades D, van den Hurk C, Wolf JR, Chan RJ, Schmeel LC, Lock M, Hijal T, Cao J, Kim H, Chow E. Breast Cancer Res Treat. 2024 Aug 7. DOI: 10.1007/s10549-024-07435-2


Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer. Whelan TJ, Smith S, Parpia S, Fyles AW, Bane A, Liu FF, Rakovitch E, Chang L, Stevens C, Bowen J, Provencher S, Théberge V, Mulligan AM, Kos Z, Akra MA, Voduc DK, Hijal T, Dayes IS, Pond G, Wright JR, Nielsen TO, Levine MN. N Engl J Med. 2023 Aug 17;389(7):612-619.DOI: https://doi.org/10.1056/nejmoa2302344


Recent Publications:

Adjuvant Treatment of Stage I-II Serous Endometrial Cancer: A Single Institution 20-Year experience. Akingbade A, Fabi F, Cartes R, Tsui J, Alfieri J. Curr Oncol. 2024 Jun 29;31(7):3758-3770. DOI: 10.3390/curroncol31070277


Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials. Wakkerman FC, Wu J, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LCHW, Haverkort MAD, de Jong MA, Mens JWM, Wortman BG, Nout RA, Léon-Castillo A, Powell ME, Mileshkin LR, Katsaros D, Alfieri J, Leary A, Singh N, de Boer SM, Nijman HW, Smit V, Bosse T, Koelzer VH, Creutzberg CL, Horeweg N. Lancet Oncol. 2024 Jun;25(6):779-789. DOI: 10.1016/S1470-2045(24)00142-6.

Epub 2024 Apr 30.


The Impact of Parent and Family Caregiver Roles Among Canadian Radiation Oncologists. Barry A, Elliott M, Loewen S, Alfieri J, Bowes D, Croke J, Debenham B, Keyes M, Papadakos J, Quartey NK, Stuckless T, Lajkosv K, Weiss J, Giuliani M. Int J Radiat Oncol Biol Phys. 2023 Jun 1;116(2):280-289. Epub 2022 Dec 21.

DOI: 10.1016/j.ijrobp.2022.12.020


Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer-A Single Institution Retrospective Study. Faye MD, Petruccelli Araujo M, Wissing MD, Alrabiah K, Gilbert L, Zeng X, Souhami L, Alfieri J. Curr Oncol. 2023 May 13;30(5):4966-4978. PMCID: PMC10217529. DOI: 10.3390/curroncol30050375

Supporting the future of cancer research

Leading the future of innovative techniques in women's cancers radiation treatment.

Donations for the Program for Women's Cancer Research (PWR) will be used to:

Fellowships

Student support

Research

Support fellowships in women’s cancer with the objective to provide training and research opportunities for young radiation oncologists.

Support graduate and post-doctoral students in pursuing cancer research in radiation oncology.

Cover research operating costs, including the purchase of materials, supplies, laboratory and treatment equipment, and research assistants.

Sponsorship

Visibility and maximum impact

Working together to build a mutually beneficial partnership and raise money for innovations and technologies in women's cancer research and treatments. Become a corporate sponsor and let's talk about the exposure and impact your contributions can have.


For more information on sponsorships, contact

Team PWR

Make a donation

Our expert radiation oncologists need your support to advance their research. Make a donation today to help increase survival rates and improve patient outcomes in women's cancers. You can make a difference.

Big or small, every donation makes a difference.

Official donation receipts for income tax purposes issued by the Cedars Cancer Foundation.

1310 Greene Avenue, Suite 520 | Westmount, Quebec H3Z 2B2 

Charity Registration Number: 105202501-RR0001

Join us November 19, 2024

Contact us

Questions? Additional Information: info@teamPWR.ca

Copyright © 2024. All rights reserved.